Clinical Research

Beta-blockers do not benefit heart attack patients with a normal LVEF
The new meta-analysis included data from nearly 18,000 patients. Overall, patient outcomes were quite similar for patients who did and did not undergo beta-blocker therapy.
Drones deliver AEDs for the first time in the United States
“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."
Early TAVR for asymptomatic severe AS cuts costs, improves outcomes
The study found lifetime per-patient savings from early TAVR ranged from about $2,334 in the U.K. to $19,607 in Switzerland.
Winning cash for taking blood pressure meds increases compliance
About 71% of patients in the rewards group opened their blood pressure medication on 80% of days, compared with about 34% in the control group.
Myval TAVR valve outperforms Sapien and Evolut in the late-breaking LANDMARK trial
The LANDMARK trial continues to show positive outcomes for the TAVR valve made in India.

Researchers simulate red blood cells, oxygen flow using low-frequency ultrasound

Scientists from Lithuania said the therapy could be helpful for patients struggling with lung damage from COVID-19.

Isotope used in cancer drug development shipped for clinical trials

Actinium-225 remains in short supply, slowing drug research.

Premature births can be predicted at 23 weeks using ultrasound

The method was developed based on 22 years of research and has been shown effective in a new study.

UVA Health receives $3.1M grant for using ultrasound to deliver drugs into the brain

Researchers are aiming to use ultrasound to breach the blood-brain barrier and deliver drug therapies.

Samin Sharma, MD, director of interventional cardiology and director of clinical cardiology, Mount Sinai Hospital, New York, discusses the first-in-human use of the Magenta Elevate percutaneous left ventricular assist device (pLVAD) with a small 10 French size and 5.5 liters per minute of hemodynamic support.

Initial results promising for world's smallest percutaneous heart pump

A new 10 French percutaneous heart pump could help greatly reduce vascular complications and improve cardiogenic shock outcomes.

Pre-clinical images of the Abbott Volt pulsed field ablation system creating lesions using electroporation, presented at the 2023 AHA Scientific Sessions, The Abbott PFA system is now being used in a first-in-human study at the Centre for Heart Rhythm Disorders at the University of Adelaide, Australia.

First patients treated with Abbott’s pulsed field ablation offering

According to Abbott, its Volt system was specifically designed to address weaknesses seen in other first-generation PFA offerings.

Vanderbilt University Medical Center sign

Vanderbilt scores $3.2M NIH grant to analyze MRI's role in improving epilepsy surgery

The five-year grant builds upon a growing body of research to better identify patients who would benefit from surgical interventions.

weight loss scale overweight obese lose weight pounds

TAVR in patients with severe obesity: Longer hospital stays, higher costs, more health risks

The CDC defines severe obesity, or class III obesity, as any patient with a BMI of 40 or higher. TAVR among these patients is not associated with a lower survival rate, but it does lead to many more risks.

Clinical Research

Beta-blockers do not benefit heart attack patients with a normal LVEF

Drones deliver AEDs for the first time in the United States

Early TAVR for asymptomatic severe AS cuts costs, improves outcomes

Winning cash for taking blood pressure meds increases compliance

Myval TAVR valve outperforms Sapien and Evolut in the late-breaking LANDMARK trial